Artificial Intelligence in Medicine

Toronto, Canada Founded: 2013 • Age: 13 yrs Acquired By Inspirata
AI software solutions for cancer surveillance and research are developed.

About Artificial Intelligence in Medicine

Artificial Intelligence in Medicine is a Healthcare company based in Toronto (Canada) founded in 2013, and was acquired by Inspirata in January 2018. AI software solutions for cancer surveillance and research are developed. It operates in the Healthcare and Technology sectors. Its chief executive, as recorded, is Jack Golabek. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.

Company details

Artificial Intelligence in Medicine was founded in 2013 in Toronto, Canada. AI-based software solutions are offered for cancer surveillance, prevention, research, biobanking, and medical laboratory operations. The product portfolio features Arbevio, by which AI and natural language processing are utilized to construct searchable databases from lab reports, clinic visit records, and similar sources in the healthcare sector.

  • Headquarters Toronto, Canada
  • Stage Acquired
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website aim.ca
  • Social LinkedIn Facebook
  • Acquired by Inspirata (Jan 2018)
Key Metrics

Investors in Artificial Intelligence in Medicine

Artificial Intelligence in Medicine has secured backing from 1 investor. Prominent investors backing the company include Inspirata.

All
InvestorDescriptionFounded YearDomainLocation
Digital pathology solutions for cancer diagnostics are developed by Inspirata.
2014inspirata.comTampa, United States
Premium access

Investor details for Artificial Intelligence in Medicine

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Artificial Intelligence in Medicine

1 people are tracked at Artificial Intelligence in Medicine (1 in leadership).

NameRoleGroup
Jack Golabek
CEOLeadership
Premium access

Complete people profiles for Artificial Intelligence in Medicine

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Artificial Intelligence in Medicine

2 dated milestones of Artificial Intelligence in Medicine across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Artificial Intelligence in Medicine is founded.
  2. Exit Acquired by Inspirata.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Artificial Intelligence in Medicine

Artificial Intelligence in Medicine was founded in 2013.

Artificial Intelligence in Medicine is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Jack Golabek is the CEO of Artificial Intelligence in Medicine, as recorded in our data.

Artificial Intelligence in Medicine was founded in 2013 in Toronto, Canada. AI-based software solutions are offered for cancer surveillance, prevention, research, biobanking, and medical laboratory operations. The product portfolio features Arbevio, by which AI and natural language processing are utilized to construct searchable databases from lab reports, clinic visit records, and similar sources in the healthcare sector.

Artificial Intelligence in Medicine has 1 investor. Key investors include Inspirata.

Yes. Artificial Intelligence in Medicine was acquired by Inspirata in January 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available